樂觀
$2.58
情境價格
$1.930
-0.156 (-8.10%)收盤時
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
Helius Medical Technologies Inc (HSDT) is not a good buy right now due to its current price of $2.015 and a very low RSI of 21.258, indicating oversold conditions. The stock has also seen a significant decline of 55.71% over the past year, which raises concerns about its long-term viability. While the forward P/E is 0, suggesting potential for future earnings, the recent performance and negative sentiment surrounding the stock indicate that it may not be a suitable investment at this time.
B. Riley
$4
2026-09-22
B. Riley
2026-09-22
目標價
$4
B. Riley
—
2026-09-03
B. Riley
2026-09-03
目標價
—
B. Riley
$3
2026-04-23
B. Riley
2026-04-23
目標價
$3
Maxim Group
—
2024-10-16
Maxim Group
2024-10-16
目標價
—
Roth MKM
$24
2024-03-05
Roth MKM
2024-03-05
目標價
$24
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

North Korea Denies Links to Binance Hack Allegations

Solana Company Designated as Strategic Enterprise by Hong Kong Government

Solana Company Announces Governance Voting Positions Ahead of SGPs

Solana Co Reports Q2 2026 Earnings with Mixed Results

Solana Company Reports Larger Than Expected Quarterly Loss
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders. It operates in the Financials sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
Helius Medical Technologies Inc (HSDT) is not a good buy right now due to its current price of $2.015 and a very low RSI of 21.258, indicating oversold conditions. The stock has also seen a significant decline of 55.71% over the past year, which raises concerns about its long-term viability. While the forward P/E is 0, suggesting potential for future earnings, the recent performance and negative sentiment surrounding the stock indicate that it may not be a suitable investment at this time.
1 analysts cover HSDT: 1 rate it Buy, 0 Hold and 0 Sell.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。